Treatment Outcomes after Postoperative Radiotherapy in Triple-Negative Breast Cancer: Multi-Institutional Retrospective Study (KROG 17-05)
- Jin Hee Kim 1, Sang Jun Byun 1, Myeongsoo Kim 1, Kyung Hwan Shin 2, Dong Yun Kim 2,3, Han Byoel Lee 4, Tae Hyun Kim 5, Yeon Joo Kim 5, Yong Bae Kim 6, Jee Suk Chang 6, Kyubo Kim 7,8, Sun Young Lee 9
- Jin Hee Kim 1, Sang Jun Byun 1, Myeongsoo Kim 1
- 1Department of Radiation Oncology, Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero Dalseo-gu, Daegu 42601, Republic of Korea.
- 2Department of Radiation Oncology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
- 3Department of Radiation Oncology, Chung-Ang University Hospital, Seoul 06973, Republic of Korea.
- 4Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
- 5Department of Radiation Oncology, Proton Therapy Center, National Cancer Center, Goyang 10408, Republic of Korea.
- 6Department of Radiation Oncology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- 7Department of Radiation Oncology, Ewha Womans University School of Medicine, Seoul 07804, Republic of Korea.
- 8Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul 03080, Republic of Korea.
- 9Department of Radiation Oncology, Chonbuk National University Hospital, Jeonju 54907, Republic of Korea.
- 0Department of Radiation Oncology, Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero Dalseo-gu, Daegu 42601, Republic of Korea.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Postoperative radiotherapy for triple-negative breast cancer (TNBC) in South Korea showed high survival rates. T and N stages, lympho-vascular invasion, and Ki-67 expression are key prognostic factors for patient outcomes.
Area Of Science
- Oncology
- Radiotherapy
- Breast Cancer Research
Background
- Triple-negative breast cancer (TNBC) presents unique challenges in treatment and prognosis.
- Postoperative radiotherapy (PORT) is a critical component of TNBC management.
- Understanding failure patterns and prognostic factors after PORT is essential for improving patient outcomes.
Purpose Of The Study
- To investigate failure patterns, survival rates, and prognostic factors in South Korean TNBC patients receiving PORT.
- To identify key clinical and biological factors influencing outcomes after PORT for TNBC.
Main Methods
- A multi-institutional retrospective study involving 699 TNBC patients who underwent PORT.
- Data collected from six institutions between 2008 and 2010, with a median follow-up of 94 months.
- Analysis included overall survival, loco-regional relapse-free survival (LRRFS), distant metastasis-free survival (DMFS), and disease-free survival (DFS).
Main Results
- Patients achieving pathologic complete remission after neoadjuvant chemotherapy showed no treatment failure.
- Distant metastasis was the primary cause of treatment failure.
- Five-year survival rates: overall (91.4%), LRRFS (92.3%), DMFS (89.4%), and DFS (85.2%).
- T and N stages, lympho-vascular invasion (LVI), and Ki-67 expression were significant prognostic factors.
Conclusions
- T and N stages, LVI, and Ki-67 expression are significantly associated with survival outcomes in TNBC patients post-PORT.
- These factors can aid in risk stratification and personalized treatment strategies for TNBC.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

